NeuroSense Therapeutics Ltd. logo

NeuroSense Therapeutics Ltd.

NRSN | NASDAQ
Chart Builder DCF Calculator
$1.32
-$0.67 (-33.67%)
Nov 2, 2026, 1:12 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Cash & Equivalents
166K 3.38M 2.64M 3.54M 11.06M 699K
Short-Term Investments
n/a n/a n/a 3.55M n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a 37K
Other Long-Term Assets
22K 23K 22K 23K n/a n/a
Receivables
33K 164K 166K 131K 178K 30K
Inventory
n/a n/a n/a n/a -178K -67
Other Current Assets
47K 35K 40K 36K 217K 67
Total Current Assets
778K 4.4M 2.92M 7.38M 11.41M 729K
Property-Plant & Equipment
228K 150K 247K 306K 19K 13K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
250K 173K 269K 329K 19K 50K
Total Assets
1.03M 4.58M 3.19M 7.71M 11.43M 779K
Account Payables
799K 1.16M 1.46M 498K 39K 55K
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a
Other Current Liabilities
n/a n/a n/a 370K 443K 29K
Total Current Liabilities
2.52M 1.99M 3.46M 1.73M 597K 120K
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 1.41M 218K 1.83M n/a
Total Long-Term Liabilities
72K n/a 1.49M 365K 1.83M n/a
Total Liabilities
2.59M 1.99M 4.94M 2.09M 2.43M 120K
Total Debt
170K 73K 142K 211K n/a n/a
Book Value
-1.56M 2.58M -1.76M 5.62M 9.01M 659K
Book Value Per Share
-1.22 2.78 -2.58 9.77 16.59 2.39
Common Stock
n/a n/a n/a n/a n/a 1K
Retained Earnings
-47.79M -36.66M -26.12M -20.79M -8.45M -4.41M
Comprehensive Income
n/a n/a n/a n/a n/a n/a
Shareholders Equity
-1.56M 2.58M -1.76M 5.62M 9.01M 659K
Total Investments
n/a n/a n/a 3.55M n/a 37K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.